Sara Tramazzo

Sara Tramazzo, a specialist from Stony Brook University, discusses the long-term outcomes for patients with psychotic disorders, revealing lower recovery rates compared to other studies. She highlights challenges in tracking patients over 25 years and the importance of differentiating between recovery and remission. Dr. Ned Kalin joins later to explore innovative treatment approaches and the potential use of neuromelanin as a biomarker in first-episode schizophrenia. Together, they shed light on the complex landscape of long-term psychiatric care.